CONNECT WITH US
HealthTech

HealthTech

Clinical support tool helps primary care health professionals detect and treat chronic kidney disease

Medical Xpress logo

Published on

Add as a preferred source on Google
Clinical support tool helps primary care health professionals detect and treat chronic kidney disease

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Investigators have developed and validated a clinical decision support tool to improve the diagnosis and treatment of chronic kidney disease (CKD) at the point of care. The research was presented at ASN Kidney Week 2026, Oct. 22–25.

Called Treat CKD, the tool draws on electronic health records data to identify CKD, classify risk by Kidney Disease: Improving Global Outcomes criteria, calculate kidney failure risk using the Kidney Failure Risk Equation, estimate cardiovascular risk using American Heart Association PREVENT equations, and provide recommendations for albuminuria testing, blood pressure management, cholesterol-lowering therapy, cardio-kidney therapies and nephrology referral.

When incorporated into the University of California, San Francisco's system, primary care health care professionals described it as easy to use, clinically relevant and well integrated into workflows without adding substantial workflow burden.

Treat CKD accurately confirmed Kidney Disease: Improving Global Outcomes–based CKD risk classification and was fully concordant with the manually calculated Kidney Failure Risk Equation and PREVENT risk scores.

D. candidate at the University of California San Francisco School of Medicine.



Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.